Szyman Catherine M. 4
4 · Edwards Lifesciences Corp · Filed May 9, 2024
Insider Transaction Report
Form 4
Szyman Catherine M.
CVP, Critical Care & Vascular
Transactions
- Tax Payment
Common Stock
2024-05-07$85.09/sh−609$51,820→ 76,992.437 total - Award
Common Stock
2024-05-07+32,025→ 77,601.437 total
Footnotes (1)
- [F1]These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.